These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37916149)

  • 1. A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass.
    Hernández-Montoliu L; Rodríguez-Peña MM; Puig R; Astiarraga B; Guerrero-Pérez F; Virgili N; López-Urdiales R; Osorio J; Monseny R; Lazzara C; Sobrino L; Pérez-Maraver M; Pérez-Prieto M; Pellitero S; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Front Endocrinol (Lausanne); 2023; 14():1181744. PubMed ID: 37916149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication.
    Casajoana A; Pujol J; Garcia A; Elvira J; Virgili N; de Oca FJ; Duran X; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Obes Surg; 2017 Sep; 27(9):2235-2245. PubMed ID: 28451931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
    Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
    Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
    Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
    Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
    Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential GIP/GLP-1 intestinal cell distribution in diabetics' yields distinctive rearrangements depending on Roux-en-Y biliopancreatic limb length.
    Palha AM; Pereira SS; Costa MM; Morais T; Maia AF; Guimarães M; Nora M; Monteiro MP
    J Cell Biochem; 2018 Sep; 119(9):7506-7514. PubMed ID: 29761876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery.
    Blanco J; Jiménez A; Casamitjana R; Flores L; Lacy A; Conget I; Vidal J
    Surg Obes Relat Dis; 2014; 10(1):9-13; quiz 189-90. PubMed ID: 24342036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass.
    Purnell JQ; Johnson GS; Wahed AS; Dalla Man C; Piccinini F; Cobelli C; Prigeon RL; Goodpaster BH; Kelley DE; Staten MA; Foster-Schubert KE; Cummings DE; Flum DR; Courcoulas AP; Havel PJ; Wolfe BM
    Diabetologia; 2018 May; 61(5):1142-1154. PubMed ID: 29428999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.
    Castagneto Gissey L; Casella Mariolo J; Mingrone G
    Peptides; 2018 Feb; 100():114-122. PubMed ID: 29412812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Bone Mineral Density in Patients with Type 2 Diabetes After Different Bariatric Surgery Procedures and the Role of Gastrointestinal Hormones.
    Guerrero-Pérez F; Casajoana A; Gómez-Vaquero C; Virgili N; López-Urdiales R; Hernández-Montoliu L; Pujol-Gebelli J; Osorio J; Alves C; Perez-Maraver M; Pellitero S; Vidal-Alabró A; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Obes Surg; 2020 Jan; 30(1):180-188. PubMed ID: 31420830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes.
    Laferrère B; Heshka S; Wang K; Khan Y; McGinty J; Teixeira J; Hart AB; Olivan B
    Diabetes Care; 2007 Jul; 30(7):1709-16. PubMed ID: 17416796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
    Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
    Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
    De Bandt D; Rives-Lange C; Frigout Y; Bergerot D; Blanchard A; Le Gall M; Lacorte JM; Chevallier JM; Czernichow S; Poghosyan T; Carette C; Le Beyec J
    Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery.
    Hansen EN; Tamboli RA; Isbell JM; Saliba J; Dunn JP; Marks-Shulman PA; Abumrad NN
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G795-802. PubMed ID: 21372167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.